Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Onglyza
Pharma
AstraZeneca steps up its Farxiga game with CV outcomes win
With data showing Farxiga can reduce hospitalizations for heart failure or CV deaths against placebo, AZ plans to seek a label update.
Eric Sagonowsky
Sep 24, 2018 11:55am
ADA: AZ exec 'very optimistic' about Farxiga outcomes study
Jun 27, 2018 11:37am
BMS, AZ in legal hot seat over Onglyza heart failure warning
May 8, 2017 11:31am
AZ bounces back with diabetes combo win
Feb 28, 2017 11:33am
AZ's FDA-rejected diabetes combo grabs first-to-market status in Europe
Jul 20, 2016 8:39am
AstraZeneca puts top brands on one-size-fits all mobile app
Jun 19, 2016 11:34am
